InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
LPS-PG (Lipopolysaccharide from P. gingivalis) | Remodeling immune microenvironment in periodontitis using resveratrol liposom... | 2021 | J Nanobiotechnology | Shi J. et al. | DOI: 10.1186/s12951-021-01175-x |
Human TLR1-9 Agonist kit | The effect of toll-like receptor ligands on energy metabolism and myokine exp... | 2021 | Sci Rep. | Tingstad R.H. et al. | DOI: 10.1038/s41598-021-03730-w |
IFN-α/β Reporter HEK 293 Cells | Nitro-fatty acids decrease type I interferons and monocyte chemoattractant pr... | 2021 | BMC Immunol. | Hansen A.L. et al. | DOI: 10.1186/s12865-021-00471-3 |
Primocin® | Brunner syndrome associated MAOA mutations result in NMDAR hyperfunction and ... | 2021 | Neurobiol Dis | van Rhijn J.R. et al. | DOI: 10.1016/j.nbd.2021.105587 |
Nano-SiO2 | Caveolin-1 negatively regulates inflammation and fibrosis in silicosis. | 2021 | J Cell Mol Med | He R. et al. | DOI: 10.1111/jcmm.17045 |
ssRNA40/LyoVec™ | Antiphospholipid antibody-induced trophoblast responses are differentially mo... | 2021 | Am J Reprod Immunol | DeSpenza R.A. et al. | DOI: 10.1111/aji.13516 |
c-di-GMP | An alternatively spliced STING isoform localizes in the cytoplasmic membrane ... | 2021 | J Clin Invest | Li X. et al. | DOI: 10.1172/JCI144339 |
2'3'-cGAMP | An alternatively spliced STING isoform localizes in the cytoplasmic membrane ... | 2021 | J Clin Invest | Li X. et al. | DOI: 10.1172/JCI144339 |
B16-Blue™ ISG-KO-STING Cells | An alternatively spliced STING isoform localizes in the cytoplasmic membrane ... | 2021 | J Clin Invest | Li X. et al. | DOI: 10.1172/JCI144339 |
ODN 1826 - TLR9 ligand | Bioadhesive injectable hydrogel with phenolic carbon quantum dot supported Pd... | 2022 | Biomaterials | He H. et al. | DOI: 10.1016/j.biomaterials.2021.121272 |
3p-hpRNA - RIG-I agonist | SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibro... | 2021 | Cell | Wendisch D. et al. | DOI: 10.1016/j.cell.2021.11.033 |
R848 (Resiquimod) | SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibro... | 2021 | Cell | Wendisch D. et al. | DOI: 10.1016/j.cell.2021.11.033 |
3-Methyladenine | Investigation of the role of the autophagic protein LC3B in the regulation of... | 2021 | Mater Today Bio | Chen S.L. et al. | DOI: 10.1016/j.mtbio.2021.100182 |
Human IL-1α & IL-1β Reporter HEK 293 Cells | First-in-human phase 1 dose-escalation study of CAN04, a first-in-class inter... | 2021 | Br J Cancer | Robbrecht D. et al. | DOI: 10.1038/s41416-021-01657-7 |
HEK-Blue™ Detection | Virulence, immunogenicity and live vaccine potential of aroA and phoP mutants... | 2021 | Microb Pathog | Swain B. et al. | DOI: 10.1016/j.micpath.2021.105355 |
Mouse TLR4 Reporter HEK293 Cells (NF-κB) | Virulence, immunogenicity and live vaccine potential of aroA and phoP mutants... | 2021 | Microb Pathog | Swain B. et al. | DOI: 10.1016/j.micpath.2021.105355 |
Mouse TLR5 Reporter HEK293 Cells (NF-κB) | Virulence, immunogenicity and live vaccine potential of aroA and phoP mutants... | 2021 | Microb Pathog | Swain B. et al. | DOI: 10.1016/j.micpath.2021.105355 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavio... | 2021 | Brain Behav Immun | Frank M.G. et al. | DOI: 10.1016/j.bbi.2021.12.007 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavio... | 2021 | Brain Behav Immun | Frank M.G. et al. | DOI: 10.1016/j.bbi.2021.12.007 |
EndoFit™ OVA protein | Combined delivery of TLR2 and TLR7 agonists by Nanostructured Lipid Carriers ... | 2021 | Int J Pharm | Kaur A. et al. | DOI: 10.1016/j.ijpharm.2021.121378 |